Completed
CCK1R Function in Patient Leukocytes
NCT03121755
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +13 more
- Locations
-
Not specified
Clinical trial condition
Metabolic Syndrome
Explore clinical trials studying Metabolic Syndrome. Study availability and eligibility vary by location and protocol.
1,081 public trials
118 recruiting studies
Metabolic Syndrome trial results
NCT02129725
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT03119493
- Conditions
- Behavior, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Laís Manata Vanzella Presidente Prudente, São Paulo, Brazil
NCT01488734
- Conditions
- Avitaminosis, Deficiency Diseases, Diabetes Mellitus, +12 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT02562573
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +7 more
- Locations
-
- Edmonton, Alberta, Canada
NCT00855374
- Conditions
- Acute Coronary Syndrome, Arterial Occlusive Diseases, Arteriosclerosis, +15 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT01334554
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +10 more
- Locations
-
- Vanderbilt University Nashville, Tennessee, United States
Completed
White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study
NCT01758601
- Conditions
- Cardiovascular Risk Factors, Glucose Metabolism Disorders, Hyperinsulinism, +4 more
- Locations
-
- Hospital Universitario Ramón y Cajal Madrid, Spain
NCT00543985
- Conditions
- Behavior, Body Weight, Glucose Metabolism Disorders, +12 more
- Locations
-
Not specified
Completed
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
NCT00394745
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Investigative Centers, Germany
- Novartis Basel, Switzerland